Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial.
Paracetamol
Patent ductus arteriosus
Preterm infant
Journal
European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
12
06
2020
accepted:
10
08
2020
revised:
06
08
2020
pubmed:
6
9
2020
medline:
24
6
2021
entrez:
5
9
2020
Statut:
ppublish
Résumé
Our aim was to assess the efficacy and safety of intravenous (i.v.) paracetamol vs. i.v. ibuprofen for the treatment of hemodynamically significant patent ductus arteriosus (hsPDA) in preterm infants. This is a multicenter randomized controlled study. Infants with a gestational age of 25
Identifiants
pubmed: 32888085
doi: 10.1007/s00431-020-03780-8
pii: 10.1007/s00431-020-03780-8
pmc: PMC7886841
doi:
Substances chimiques
Acetaminophen
362O9ITL9D
Ibuprofen
WK2XYI10QM
Banques de données
ClinicalTrials.gov
['NCT02422966']
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
807-816Commentaires et corrections
Type : CommentIn
Références
Hamrick SE, Hansmann G (2010) Patent ductus arteriosus of the preterm infant. Pediatrics 125:1020–1030
doi: 10.1542/peds.2009-3506
El-Khuffash A, Weisz DE, McNamara PJ (2016) Reflections of the changes in patent ductus arteriosus management during the last 10 years. Arch Dis Child Fetal Neonatal Ed 101:F474–F478
doi: 10.1136/archdischild-2014-306214
Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K (2005) Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 90:F235–F239
doi: 10.1136/adc.2004.057638
Kaempf JW, Wu XY, Kaempf AJ, Kaempf AM, Wang L, Grunkemeier G (2012) What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants? J Perinatol 32:344–348
doi: 10.1038/jp.2011.102
Liebowitz M, Clyman RI (2017) Prophylactic indomethacin compared with delayed conservative management of the patent ductus arteriosus in extremely preterm infants: effects on neonatal outcomes. J Pediatr 187:119–126
doi: 10.1016/j.jpeds.2017.03.021
Schena F, Francescato G, Cappelleri A, Picciolli I, Mayer A, Mosca F, Fumagalli M (2015) Association between hemodynamically significant patent ductus arteriosus and bronchopulmonary dysplasia. J Pediatr 166:1488–1492
doi: 10.1016/j.jpeds.2015.03.012
Malviya MN, Ohlsson A, Shah SS (2013) Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 3:CD003951
Fowlie PW, Davis PG (2012) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 3:CD000174
Ohlsson A, Walia R, Shah SS (2018) Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev 9:CD003481
pubmed: 30264852
Hammerman C, Bin-Nun A, Kaplan M (2012) Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew. Semin Perinatol 36:130–138
doi: 10.1053/j.semperi.2011.09.023
Thomas RL, Parker GC, Van Overmeire B, Aranda JV (2005) A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 164:135–140
doi: 10.1007/s00431-004-1596-5
Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H (2013) Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One 8:e77888
doi: 10.1371/journal.pone.0077888
Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, Canpolat FE, Dilmen U (2014) Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 164:510–514
doi: 10.1016/j.jpeds.2013.11.008
El-Mashad AE, El-Mahdy H, El Amrousy D, Elgendy M (2017) Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr 176:233–240
doi: 10.1007/s00431-016-2830-7
Ohlsson A, Shah PS (2018) Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev 4:CD01006
Marconi E, Bettiol A, Ambrosio G, Perduca V, Vannacci A, Troiani S, Dani C, Mugelli A, Lucenteforte E (2019) Efficacy and safety of pharmacological treatments for patent ductus arteriosus closure: a systematic review and network meta-analysis of clinical trials and observational studies. Pharmacol Res 148:104418
doi: 10.1016/j.phrs.2019.104418
Dani C, Poggi C, Cianchi I, Corsini I, Vangi V, Pratesi S (2018) Effect on cerebral oxygenation of paracetamol for patent ductus arteriosus in preterm infants. Eur J Pediatr 177:533–539
doi: 10.1007/s00431-018-3086-1
Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Håkansson S, Lindqvist J, Farooqi A, Katheria A, Sauberan J, Singh J, Nelson K, Wickremasinghe A, Dong L, Hassinger DC, Aucott SW, Hayashi M, Heuchan AM, Carey WA, Derrick M, Wolf IS, Kimball A, Sankar M, Leone T, Perez J, Serize A, Clyman RI (2019) Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320). J Perinatol 39:599–607
doi: 10.1038/s41372-019-0347-4
Dani C et al (2019) Patent ductus arteriosus in preterm infants born at 23-24 weeks’ gestation: Should we pay more attention? Early Hum Dev. 135:16–22
doi: 10.1016/j.earlhumdev.2019.06.002
Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV (1996) Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 275:539–544
doi: 10.1001/jama.1996.03530310045031
Su BH, Lin HC, Chiu HY, Hsieh HY, Chen HH, Tsai YC (2008) Comparison of ibuprofen and indomethacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomized controlled trial. Arch Dis Child Fetal Neonatal Ed 93:F94–F99
doi: 10.1136/adc.2007.120584
Rosenthal P (1997) Assessing liver function and hyperbilirubinemia in the newborn. Clin Chem 43:228–234
doi: 10.1093/clinchem/43.1.228
Dani C, Poggi C, Mosca F, Schena F, Lista G, Ramenghi L, Romagnoli C, Salvatori E, Rosignoli MT, Lipone P, Comandini A (2016) Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial. Trials 17:182
doi: 10.1186/s13063-016-1294-4
Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8
doi: 10.1097/01.PCC.0000149131.72248.E6
Papile LS, Burstein J, Burstein R, Koffler H (1978) Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants weighing less than 1500 grams. J Pediatr 92:529–534
doi: 10.1016/S0022-3476(78)80282-0
de Vries LS, Eken P, Dubowitz LM (1992) The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 49:1–6
doi: 10.1016/S0166-4328(05)80189-5
Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K (2005) Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116:1353–1360
doi: 10.1542/peds.2005-0249
(2005) The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123:991–999
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T (1978) Neonatal necrotizing enterocolitis: therapeutic decisions based on clinical staging. Ann Surg 187:1–7
doi: 10.1097/00000658-197801000-00001
Dani C, Vangi V, Bertini G, Pratesi S, Lori I, Favelli F, Ciuti R, Bandinelli A, Martano C, Murru P, Messner H, Schena F, Mosca F (2012) High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clin Pharmacol Ther 91:590–596
doi: 10.1038/clpt.2011.284
Yurttutan S, Oncel MY, Arayicı S, Uras N, Altug N, Erdeve O, Dilmen U (2013) A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med 26:825–827
doi: 10.3109/14767058.2012.755162
Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, Zea AM, Zhang Y, Sadeghirad B, Thabane L (2018) Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA 319:1221–1238
doi: 10.1001/jama.2018.1896
Roofthooft DW, van Beynum IM, Helbing WA, Reiss IK, Simons SH (2013) Paracetamol for ductus arteriosus closure: not always a success story. Concerning the article by M.Y. Oncel et al. intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 104:170
doi: 10.1159/000353451
Alan S, Kahvecioglu D, Erdeve O, Atasay B, Arsan S (2013) Is paracetamol a useful treatment for ibuprofen-resistant patent ductus arteriosus? Concerning the article by M.Y. Oncel et al. intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 104:168–169
doi: 10.1159/000352068
El-Khuffash A et al (2014) Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies. Pediatr Res 76:238–244
doi: 10.1038/pr.2014.82
van der Lugt NM, Lopriore E, Bökenkamp R, Smits-Wintjens VEHJ, Steggerda SJ, Walther FJ (2012) Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus. Eur J Pediatr 171:1673–1677
doi: 10.1007/s00431-012-1805-6
Olgun H, Ceviz N, Kartal İ, Caner İ, Karacan M, Taştekin A, Becit N (2017) Repeated courses of oral ibuprofen in premature infants with patent ductus arteriosus: efficacy and safety. Pediatr Neonatol 58:29–35
doi: 10.1016/j.pedneo.2015.04.017
Chen JX, O’Mara PW, Poole SD, Brown N, Ehinger NJ, Slaughter JC, Paria BC, Aschner JL, Reese J (2012) Isoprostanes as physiological mediators of transition to newborn life, novel mechanisms regulating patency of the term and preterm ductus arteriosus. Pediatr Res 72:122–128
doi: 10.1038/pr.2012.58